{
    "clinical_study": {
        "@rank": "68914", 
        "arm_group": {
            "arm_group_label": "Zimmer TM Total Ankle System", 
            "arm_group_type": "Other", 
            "description": "Primary or revision total ankle arthroplasty subjects that receive the Zimmer Trabecular Metal Total Ankle System"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to obtain implant survivorship and clinical outcome\n      data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary\n      or revision total ankle arthroplasty.  The assessment will include implant survivorship and\n      clinical performance measured by pain and function, quality of life data, radiographic\n      parameters and survivorship."
        }, 
        "brief_title": "Zimmer Trabecular Metal Total Ankle", 
        "completion_date": {
            "#text": "January 2027", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Degenerative Arthritis", 
            "Rheumatoid Arthritis", 
            "Post-traumatic Arthritis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Osteoarthritis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study design is a prospective, multicenter, study of the commercially available Zimmer\n      Trabecular Metal Ankle semiconstrained implants.  The study will require each site to obtain\n      Institutional Review Board approval prior to study enrollment.  All potential study subjects\n      will be required to participate in the Informed Consent Process.\n\n      All study subjects will undergo preoperative clinical evaluations prior to their primary or\n      revision total ankle arthroplasty.  The post-operative clinical and radiographic evaluations\n      will be conducted at 6 weeks, 6 month, 1 year, 2, 3, 5, 7, and 10 years. Follow-up surveys\n      will occur at 4, 6, 8, and 9 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient is > 18 years of age\n\n          -  The patient is skeletally mature\n\n          -  The patient qualifies for primary or revision total ankle replacement based on\n             physical exam and medical history including the following: degenerative arthritis,\n             rheumatoid arthritis, post-traumatic arthritis.\n\n          -  The patient is willing and able to provide written informed consent\n\n          -  Patient is willing and able to cooperate in the required post-operative therapy\n\n          -  The patient is willing and able to complete scheduled follow-up evaluations\n             questionnaires as described in the Informed Consent\n\n          -  The patient has participated in the Informed Consent process and has signed the\n             Institutional Review Board/European Commission approved Informed Consent\n\n        Exclusion Criteria:\n\n          -  The patient is: a prisoner, mentally incompetent or unable to understand what\n             participation in the study entails, a known alcohol or drug abuser, anticipated to be\n             non-compliant.\n\n          -  The patient has one of the following compromising the affected limb: ankle\n             arthrodesis with malleolar exeresis, severe neurological or vascular disease, loss of\n             musculature or neuromuscular compromise, severe instability, maltracking or\n             misalignment of the tibia and talus uncorrectable by surgery.\n\n          -  The patient has a local/systemic infection that may affect the prosthetic joint\n\n          -  The patient has a previous history of infection in the affected joint\n\n          -  The patient is known to be pregnant\n\n          -  The patient has insufficient bone stock or bone quality to fix the components (i.e.\n             osteoporosis, Charcot's disease)\n\n          -  The patient has a known sensitivity or allergic reaction to one or more of the\n             implanted materials\n\n          -  The patient is unwilling or unable to give consent or to comply with the follow-up\n             program"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02038140", 
            "org_study_id": "CSU2011-07E"
        }, 
        "intervention": {
            "arm_group_label": "Zimmer TM Total Ankle System", 
            "description": "Primary or revision total ankle replacement", 
            "intervention_name": "Zimmer Trabecular Metal Total Ankle System", 
            "intervention_type": "Device", 
            "other_name": [
                "Primary Ankle Replacement", 
                "Total Ankle Arthroplasty", 
                "Total Ankle Replacement"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Primary Ankle Replacement", 
            "Total Ankle Arthroplasty", 
            "Total Ankle Replacement", 
            "Trabecular Metal Total Ankle"
        ], 
        "lastchanged_date": "January 14, 2014", 
        "number_of_arms": "1", 
        "official_title": "Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer\u00ae Trabecular Metal\u2122 Total Ankle", 
        "overall_contact": {
            "email": "jeff.schram@zimmer.com", 
            "last_name": "Jeff A Schram, BS/MS", 
            "phone": "+1(574) 372-4666"
        }, 
        "overall_contact_backup": {
            "email": "kelly.francher@zimmer.com", 
            "last_name": "Kelly Francher, BA, CCRA", 
            "phone": "+1(574)371-8316"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2027", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Survival of the implants after 10 years which is based on removal of the prosthesis and will be determined using the Kaplan Meier Method.", 
            "measure": "Survivorship", 
            "safety_issue": "No", 
            "time_frame": "10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02038140"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Performance os the Zimmer Trabecular Metal Ankle after 2 years which is assessed by the AOFAS score.", 
            "measure": "American Orthopaedic Foot and Ankle Society Score", 
            "safety_issue": "No", 
            "time_frame": "First 2 years"
        }, 
        "source": "Zimmer, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zimmer, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}